Table 2.
NO | WMD (95%CI) | p Value | P Heterogeneity | I2 (%) | |
---|---|---|---|---|---|
Effect of saffron supplementation on SBP | |||||
Overall effect | 10 | −0.65 (−1.12, −0.18) | 0.006 | 0.049 | 46.9% |
Baseline SBP (mmHg) | |||||
<120 | 6 | −1.57 (−2.73, −0.41) | 0.008 | 0.565 | 0.0% |
≥120 | 4 | −0.47 (−0.98, 0.03) | 0.068 | 0.017 | 70.6% |
Duration | |||||
<12 | 5 | −0.51 (−0.99, −0.03) | 0.035 | 0.729 | 0.0% |
≥12 | 5 | −4.00 (−6.34, −1.67) | 0.001 | 0.155 | 40.0% |
Intervention dose (mg) | |||||
≥100 | 7 | −0.56 (−1.03, −0.09) | 0.019 | 0.160 | 35.1% |
<100 | 3 | −4.50 (−7.61, −1.40) | 0.004 | 0.436 | 0.0% |
Intervention type | |||||
Saffron | 7 | −0.58 (−1.05, −0.11) | 0.016 | 0.136 | 38.4% |
Crocin | 3 | −5.84 (−9.81, −1.87) | 0.004 | 0.755 | 0.0% |
Effect of saffron supplementation on DBP | |||||
Overall effect | 8 | −1.23 (−1.64, −0.81) | <0.001 | 0.928 | 0.0% |
Baseline DBP (mmHg) | |||||
<80 | 5 | 0.66 (−2.50, 3.83) | 0.681 | 0.959 | 0.0% |
≥80 | 3 | −1.26 (−1.68, −0.84) | <0.001 | 0.800 | 0.0% |
Duration | |||||
<12 | 5 | −1.25 (−1.68, −0.83) | <0.001 | 0.883 | 0.0% |
≥12 | 3 | 0.45(−2.77, 3.69) | 0.782 | 0.882 | 0.0% |
Intervention dose (mg) | |||||
≥100 | 7 | −1.23 (−1.65, −0.81) | <0.001 | 0.871 | 0.0% |
<100 | 1 | −1.01 (−7.94, 5.92) | 0.775 | - | - |
Intervention type | |||||
Saffron | 6 | −1.23 (−1.65, −0.81) | <0.001 | 0.806 | 0.0% |
Crocin | 2 | −0.38 (−5.89, 5.13) | 0.892 | 0.769 | 0.0% |
Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure.